Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Demeure

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancers|March 25, 2022
Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene FusionsSourat Darabi, Andrew Elliott, David R Braxton, et al.
Plos One|November 9, 2013
A pilot study using next-generation sequencing in advanced cancers: feasibility and challengesGlen J Weiss, Winnie S Liang, Michael J Demeure, et al.
The Lancet. Oncology|March 22, 2015
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 studyMartin Fassnacht, Alfredo Berruti, Eric Baudin, et al.
Frontiers in Oncology|May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of LeiomyosarcomaGalina Lagos, Roman Groisberg, Andrew Elliott, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studiesLynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
Gastroenterology|July 19, 2022
An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort StudyKota Nakamura, Zhongxu Zhu, Souvick Roy, et al.
Plos One|October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencingWinnie S Liang, David W Craig, John Carpten, et al.
Cancer Cell|May 12, 2016
Comprehensive Pan-Genomic Characterization of Adrenocortical CarcinomaSiyuan Zheng, Andrew D Cherniack, Ninad Dewal, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancers|March 25, 2022
Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene FusionsSourat Darabi, Andrew Elliott, David R Braxton, et al.
Plos One|November 9, 2013
A pilot study using next-generation sequencing in advanced cancers: feasibility and challengesGlen J Weiss, Winnie S Liang, Michael J Demeure, et al.
The Lancet. Oncology|March 22, 2015
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 studyMartin Fassnacht, Alfredo Berruti, Eric Baudin, et al.
Frontiers in Oncology|May 11, 2023
<i>ERBB</i> family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of LeiomyosarcomaGalina Lagos, Roman Groisberg, Andrew Elliott, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 8, 2024
Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studiesLynette M Smith, Douglas W Mahoney, William R Bamlet, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2021
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, et al.
Gastroenterology|July 19, 2022
An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort StudyKota Nakamura, Zhongxu Zhu, Souvick Roy, et al.
Plos One|October 17, 2012
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencingWinnie S Liang, David W Craig, John Carpten, et al.
Cancer Cell|May 12, 2016
Comprehensive Pan-Genomic Characterization of Adrenocortical CarcinomaSiyuan Zheng, Andrew D Cherniack, Ninad Dewal, et al.
Pageof 8